abstract |
The sulfonyl compound of formula I wherein R 1,nR 2, R 3, X, W, y and z are of particular interest. This compoundninter alia, it inhibits matrix metalloprotease activity. Wayntreatment, which comprises administering the compound in an effective mannernthe amount of host that is in a pathological conditionnmatrix metalloprotease activity. |